CN112806437A - High-protein probiotic solid beverage and preparation method thereof - Google Patents
High-protein probiotic solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN112806437A CN112806437A CN202011625157.5A CN202011625157A CN112806437A CN 112806437 A CN112806437 A CN 112806437A CN 202011625157 A CN202011625157 A CN 202011625157A CN 112806437 A CN112806437 A CN 112806437A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- solid beverage
- probiotic solid
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 27
- 239000007787 solid Substances 0.000 title claims abstract description 26
- 239000006041 probiotic Substances 0.000 title claims abstract description 24
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 24
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title description 7
- 239000000843 powder Substances 0.000 claims abstract description 59
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 14
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 14
- 235000021119 whey protein Nutrition 0.000 claims abstract description 14
- 229920001353 Dextrin Polymers 0.000 claims abstract description 11
- 239000004375 Dextrin Substances 0.000 claims abstract description 11
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 11
- 235000019425 dextrin Nutrition 0.000 claims abstract description 11
- 241000251468 Actinopterygii Species 0.000 claims abstract description 10
- 102000008186 Collagen Human genes 0.000 claims abstract description 10
- 108010035532 Collagen Proteins 0.000 claims abstract description 10
- 229920001436 collagen Polymers 0.000 claims abstract description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 10
- 239000002245 particle Substances 0.000 claims abstract description 8
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 8
- 235000008939 whole milk Nutrition 0.000 claims abstract description 8
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 6
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 26
- 239000003094 microcapsule Substances 0.000 claims description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 18
- 241000894006 Bacteria Species 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 14
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 13
- 239000005913 Maltodextrin Substances 0.000 claims description 13
- 229920002774 Maltodextrin Polymers 0.000 claims description 13
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 13
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 13
- 229940035034 maltodextrin Drugs 0.000 claims description 13
- 235000012239 silicon dioxide Nutrition 0.000 claims description 13
- 239000000377 silicon dioxide Substances 0.000 claims description 13
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 10
- 239000011707 mineral Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 235000018102 proteins Nutrition 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 239000008347 soybean phospholipid Substances 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 241000186660 Lactobacillus Species 0.000 claims description 9
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 229940039696 lactobacillus Drugs 0.000 claims description 9
- 239000011812 mixed powder Substances 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 7
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 7
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 244000134552 Plantago ovata Species 0.000 claims description 7
- 235000003421 Plantago ovata Nutrition 0.000 claims description 7
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 7
- 239000004376 Sucralose Substances 0.000 claims description 7
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 7
- 235000019408 sucralose Nutrition 0.000 claims description 7
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 102000011632 Caseins Human genes 0.000 claims description 6
- 108010076119 Caseins Proteins 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N pantothenic acid Chemical compound OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 6
- 229940080237 sodium caseinate Drugs 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 229940054810 white kidney bean extract Drugs 0.000 claims description 6
- -1 compound vitamin Chemical class 0.000 claims description 5
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 5
- 230000009467 reduction Effects 0.000 claims description 5
- 229940001941 soy protein Drugs 0.000 claims description 5
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 4
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 4
- 238000012371 Aseptic Filling Methods 0.000 claims description 4
- 229920002752 Konjac Polymers 0.000 claims description 4
- 238000009455 aseptic packaging Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 239000010903 husk Substances 0.000 claims description 4
- 239000000252 konjac Substances 0.000 claims description 4
- 235000010485 konjac Nutrition 0.000 claims description 4
- 239000008223 sterile water Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 3
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- 239000009223 Psyllium Substances 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 150000003904 phospholipids Chemical class 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 229940070687 psyllium Drugs 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 3
- 229960000342 retinol acetate Drugs 0.000 claims description 3
- 235000019173 retinyl acetate Nutrition 0.000 claims description 3
- 239000011770 retinyl acetate Substances 0.000 claims description 3
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 3
- 235000005282 vitamin D3 Nutrition 0.000 claims description 3
- 239000011647 vitamin D3 Substances 0.000 claims description 3
- 229940021056 vitamin d3 Drugs 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims 1
- 206010016766 flatulence Diseases 0.000 abstract description 3
- 206010025482 malaise Diseases 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 201000010538 Lactose Intolerance Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 101710162629 Trypsin inhibitor Proteins 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015816 nutrient absorption Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000021003 saturated fats Nutrition 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000002753 trypsin inhibitor Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000021278 navy bean Nutrition 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/06—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention belongs to the technical field of solid beverages, and particularly relates to a high-protein probiotic solid beverage which comprises the following component raw materials in parts by weight: 65-70 parts of soybean protein isolate, 15-20 parts of whole milk powder, 15-26 parts of resistant dextrin, 15-20 parts of malto-oligosaccharide powder, 10 parts of oat crisp particles, 15-25 parts of skimmed milk powder, 10-15 parts of whey protein and 10-15 parts of fish collagen peptide powder Flatulence and other malaise.
Description
Technical Field
The invention belongs to the technical field of solid beverages, and particularly relates to a high-protein probiotic solid beverage and a preparation method thereof.
Background
Unhealthy life styles such as drinking, smoking, long night, barbecuing, hot pot and the like, which are caused by poor diet, living habits, pressure and abuse of antibiotics, can cause imbalance of intestinal flora and influence the health of intestinal tracts; the probiotics are microbes which are beneficial to the health of human bodies, can maintain the health balance of intestinal tracts, have the functions of improving the intestinal tracts, enhancing immunity and the like, are various in types and irregular in quality on the market, mainly comprise yoghourt and solid beverages, but have fewer strains in the existing products, lower viable bacteria quantity and poorer field planting capability in the intestinal tracts, so that the effect is greatly reduced, and meanwhile, the existing probiotics solid beverage does not have the function of high protein.
Disclosure of Invention
To solve the problems set forth in the background art described above. The invention provides a high-protein probiotic solid beverage and a preparation method thereof, and the beverage has the characteristics of large strain number and high protein.
In order to achieve the purpose, the invention provides the following technical scheme: a high-protein probiotic solid beverage comprises the following component raw materials in parts by weight: 65-70 parts of isolated soy protein, 15-20 parts of whole milk powder, 15-26 parts of resistant dextrin, 15-20 parts of maltooligosaccharide powder, 10 parts of oat crisp particles, 15-25 parts of skimmed milk powder, 10-15 parts of whey protein, 10-15 parts of fish collagen peptide powder, 2-5 parts of edible lactic acid bacteria, 3-5 parts of white kidney bean extract, 4-8 parts of conjugated linoleic acid glyceride microcapsule powder, 5-9 parts of medium-chain triglyceride microcapsule powder, 1 part of compound mineral substance, 1 part of compound vitamin and 3-5 parts of soybean phospholipid.
Preferably, the composition also comprises the following component auxiliary materials in parts by weight: 2-6 parts of isomaltooligosaccharide, 1-3 parts of stachyose, 4-7 parts of konjac flour, 2 parts of psyllium husk, 3-8 parts of xanthan gum, 2-5 parts of sucralose, 7-10 parts of silicon dioxide and 2-7 parts of food essence.
Preferably, the edible lactic acid bacteria comprise maltodextrin, Lactobacillus plantarum LP45, Lactobacillus acidophilus La28, Lactobacillus paracasei YMC1069, and Bifidobacterium bifidum TMC 3115.
Preferably, the conjugated linoleic acid glyceride microcapsule powder comprises conjugated linoleic acid glyceride, oligomeric maltose, sodium caseinate, silicon dioxide and dipotassium hydrogen phosphate.
Preferably, the medium chain triglyceride microcapsule powder comprises medium chain triglyceride, resistant dextrin, sodium caseinate, silicon dioxide and sodium tripolyphosphate.
Preferably, the vitamin complex comprises dl-alpha-tocopherol acetate, retinyl acetate, D-pantothenic acid, pyridoxine hydrochloride, thiamine sulfate, nuclear sulfonic acid, cholecalciferol, nicotinic acid, folic acid, cyanocobalamin, and maltodextrin.
Preferably, the compound mineral comprises calcium carbonate, magnesium carbonate, zinc oxide and maltodextrin.
Preferably, the whey protein is concentrated whey protein, and the soybean phospholipid can be replaced by phospholipid.
A high-protein probiotic solid beverage and a preparation method thereof comprise the following steps:
the method comprises the following steps: weighing a proper amount of soybean protein isolate, whole milk powder, resistant dextrin, polymaltose powder, oat crisp particles, skimmed milk powder, whey protein, fish collagen peptide powder, white kidney bean extract, conjugated linoleic acid glyceride microcapsule powder, medium-chain triglyceride microcapsule powder, compound mineral substances, compound vitamins and soybean phospholipids, preparing a mixture, and performing bacteria reduction treatment to obtain a main material for later use;
step two: weighing appropriate amount of isomaltooligosaccharide, stachyose, rhizoma Amorphophalli powder, Plantago ovata forsk, xanthan gum, sucralose, silicon dioxide and food essence, mixing in a mixing device, and performing antibacterial treatment to obtain adjuvants;
step three: taking a proper amount of refrigerated lactobacillus plantarum LP45, lactobacillus acidophilus La28, lactobacillus paracasei YMC1069 and bifidobacterium bifidum TMC3115, airing to room temperature in a sterile environment, then injecting into a mixing device, injecting a proper amount of maltodextrin, and mixing uniformly to prepare the edible lactobacillus for later use;
step four: mixing the prepared main material and auxiliary material in a mixing device, adding appropriate amount of sterile water, stirring at 30-35 deg.C for 25-30min to obtain mixed powder, and mixing the prepared edible lactobacillus with the mixed powder uniformly;
step five: and then concentrating the prepared liquid, quickly freezing the concentrated liquid into pills, carrying out freeze-drying and crushing treatment on the structure, then carrying out aseptic filling, and packaging and coding to obtain the probiotic solid beverage.
Compared with the prior art, the invention has the beneficial effects that:
1. the invention not only reduces the intake of cholesterol and saturated fat, but also achieves the balance of nutrition intake by adopting the isolated soy protein as the main material, the soy protein can prevent the loss of urine calcium, promote the health of bones, reduce the probability of osteoporosis, and effectively reduce the content of total cholesterol and low-density lipoprotein cholesterol in human blood, thereby reducing the risk of heart disease, and meanwhile, the isolated soy protein powder removes the original nutrition inhibitor trypsin inhibitor in the soybeans, and does not worry about the uncomfortable reactions of indigestion, flatulence and the like.
2. According to the invention, by adopting edible lactic acid bacteria, under the coordination of specific 4 kinds of lactobacillus, mutual promotion of the effects of all strains is realized, and the functions of regulating intestines and stomach, promoting intestinal tract peristalsis, relieving constipation and diarrhea, reducing serum cholesterol, relieving lactose intolerance, accumulating proteolytic enzyme, regulating nutrient absorption and regulating organism immunity can be better realized.
3. According to the invention, by adopting the fish collagen peptide powder, the elastic fiber net with fracture and aging can be repaired, the skin tissue structure is reformed, wrinkles are stretched, in-vivo free radicals can be eliminated, the skin aging is slowed down by oxidation resistance, the effects of tightening the skin, enhancing the elasticity, smoothing fine lines, preventing and eliminating red blood filaments are achieved, the cell connection is tighter, the metabolism speed is accelerated, the dead skin is dropped off, the melanin deposition is prevented, the cell division and proliferation can be stimulated, and damaged cells can be differentiated and repaired to heal wounds.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Examples
The invention provides the following technical scheme: a high-protein probiotic solid beverage comprises the following component raw materials in parts by weight: 65-70 parts of soybean protein isolate, which is taken as a main material to reduce the intake of cholesterol and saturated fat and balance the nutrient intake, can prevent the loss of urine calcium, promote the bone health, reduce the probability of osteoporosis and effectively reduce the contents of total cholesterol and low-density lipoprotein cholesterol in the blood of a human body so as to reduce the risk of heart disease, simultaneously removes the original nutrition inhibition factor trypsin inhibitor in the soybean, does not worry about the uncomfortable reactions of indigestion, stomach flatulence and the like, 15-20 parts of whole milk powder, 15-26 parts of resistant dextrin, 15-20 parts of malto oligosaccharide powder, 10 parts of oat crisp particles, 15-25 parts of skim milk powder, 10-15 parts of whey protein and 10-15 parts of fish collagen peptide powder, and by adopting the fish collagen peptide powder, the elastic fiber net capable of repairing broken and aged skin tissue structure and stretching wrinkles can remove free radicals in vivo, resist oxidation and slow down skin aging, has the effects of tightening skin, enhancing elasticity, smoothing fine lines, preventing and eliminating red blood filaments, enabling cell connection to be tighter, accelerating metabolism speed, promoting dead skin to fall off, preventing melanin deposition, stimulating cell division and proliferation, differentiating and repairing damaged cells to heal wounds, and comprises 2-5 parts of edible lactic acid bacteria, 3-5 parts of white kidney bean extract, 4-8 parts of conjugated linoleic acid glyceride microcapsule powder, 5-9 parts of medium-chain triglyceride microcapsule powder, 1 part of compound mineral substance, 1 part of compound vitamin and 3-5 parts of soybean phospholipid.
Specifically, the feed also comprises the following component auxiliary materials in parts by weight: 2-6 parts of isomaltooligosaccharide, 1-3 parts of stachyose, 4-7 parts of konjac flour, 2 parts of psyllium husk, 3-8 parts of xanthan gum, 2-5 parts of sucralose, 7-10 parts of silicon dioxide and 2-7 parts of food essence.
Specifically, the edible lactic acid bacteria comprise maltodextrin, lactobacillus plantarum LP45, lactobacillus acidophilus La28, lactobacillus paracasei YMC1069 and bifidobacterium bifidum TMC3115, and the edible lactic acid bacteria are adopted to realize mutual promotion of the effects of all the bacteria under the coordination of specific 4 kinds of lactobacillus, so that the intestines and the stomach can be better regulated, the intestinal tract peristalsis is promoted, constipation and diarrhea are relieved, serum cholesterol is reduced, lactose intolerance is relieved, proteolytic enzyme is accumulated, the nutrient absorption is regulated, and the organism immunity function is regulated.
Specifically, the conjugated linoleic acid glyceride microcapsule powder comprises conjugated linoleic acid glyceride, oligomeric maltose, sodium caseinate, silicon dioxide and dipotassium hydrogen phosphate, and the medium chain triglyceride microcapsule powder comprises medium chain triglyceride, resistant dextrin, sodium caseinate, silicon dioxide and sodium tripolyphosphate.
Specifically, the compound vitamin comprises dl-alpha-tocopherol acetate, retinyl acetate, D-pantothenic acid, pyridoxine hydrochloride, thiamine sulfate, nuclear sulfonic acid, cholecalciferol, nicotinic acid, folic acid, cyanocobalamin, and maltodextrin, and the compound mineral comprises calcium carbonate, magnesium carbonate, zinc oxide, and maltodextrin.
Specifically, the whey protein is concentrated whey protein, and soybean phospholipid can be replaced by phospholipid.
A high-protein probiotic solid beverage and a preparation method thereof comprise the following steps:
the method comprises the following steps: weighing a proper amount of soybean protein isolate, whole milk powder, resistant dextrin, polymaltose powder, oat crisp particles, skimmed milk powder, whey protein, fish collagen peptide powder, white kidney bean extract, conjugated linoleic acid glyceride microcapsule powder, medium-chain triglyceride microcapsule powder, compound mineral substances, compound vitamins and soybean phospholipids, preparing a mixture, and performing bacteria reduction treatment to obtain a main material for later use;
step two: weighing appropriate amount of isomaltooligosaccharide, stachyose, rhizoma Amorphophalli powder, Plantago ovata forsk, xanthan gum, sucralose, silicon dioxide and food essence, mixing in a mixing device, and performing antibacterial treatment to obtain adjuvants;
step three: taking a proper amount of refrigerated lactobacillus plantarum LP45, lactobacillus acidophilus La28, lactobacillus paracasei YMC1069 and bifidobacterium bifidum TMC3115, airing to room temperature in a sterile environment, then injecting into a mixing device, injecting a proper amount of maltodextrin, and mixing uniformly to prepare the edible lactobacillus for later use;
step four: mixing the prepared main material and auxiliary material in a mixing device, adding appropriate amount of sterile water, stirring at 30-35 deg.C for 25-30min to obtain mixed powder, and mixing the prepared edible lactobacillus with the mixed powder uniformly;
step five: and then concentrating the prepared liquid, quickly freezing the concentrated liquid into pills, carrying out freeze-drying and crushing treatment on the structure, then carrying out aseptic filling, and packaging and coding to obtain the probiotic solid beverage.
The working principle and the using process of the invention are as follows: the preparation method comprises the steps of weighing a proper amount of soybean protein isolate, whole milk powder, resistant dextrin, polymaltose powder, oat crisp granules, skimmed milk powder, whey protein, fish collagen peptide powder, navy bean extract, conjugated linoleic acid glyceride microcapsule powder, medium-chain triglyceride microcapsule powder, compound minerals, compound vitamins and soybean phospholipids to prepare a mixture, carrying out bacteria reduction treatment on the mixture to obtain a main material for later use, weighing a proper amount of isomaltooligosaccharide, stachyose, konjac powder, Plantago ovata seed husk, xanthan gum, sucralose, silicon dioxide and food essence, uniformly mixing the mixture in a mixing device, carrying out bacteria reduction treatment to obtain an auxiliary material for later use, taking a proper amount of refrigerated lactobacillus plantarum LP45, lactobacillus acidophilus La28, lactobacillus paracasei YMC1069 and bifidobacterium bifidum TMC3115, airing the mixture to room temperature in an aseptic environment, injecting the mixture into a mixing device, and injecting a proper amount of maltodextrin to mix uniformly to prepare edible lactic acid bacteria for later use, putting the prepared main material and auxiliary material into a mixing device to mix, then adding a proper amount of sterile water, stirring for 25-30min at the temperature of 30-35 ℃ to obtain mixed powder, then uniformly mixing the prepared edible lactic acid bacteria and the mixed powder, finally concentrating the prepared liquid, quickly freezing into pellet-shaped particles, freeze-drying the structure, crushing, then carrying out aseptic filling, and packaging and coding to obtain the probiotic solid beverage.
Finally, it should be noted that: although the present invention has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that changes may be made in the embodiments and/or equivalents thereof without departing from the spirit and scope of the invention. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (9)
1. A high-protein probiotic solid beverage is characterized in that: the composite material comprises the following raw materials in parts by weight: 65-70 parts of isolated soy protein, 15-20 parts of whole milk powder, 15-26 parts of resistant dextrin, 15-20 parts of maltooligosaccharide powder, 10 parts of oat crisp particles, 15-25 parts of skimmed milk powder, 10-15 parts of whey protein, 10-15 parts of fish collagen peptide powder, 2-5 parts of edible lactic acid bacteria, 3-5 parts of white kidney bean extract, 4-8 parts of conjugated linoleic acid glyceride microcapsule powder, 5-9 parts of medium-chain triglyceride microcapsule powder, 1 part of compound mineral substance, 1 part of compound vitamin and 3-5 parts of soybean phospholipid.
2. The high protein probiotic solid beverage according to claim 1, characterized in that: the composition also comprises the following component auxiliary materials in parts by weight: 2-6 parts of isomaltooligosaccharide, 1-3 parts of stachyose, 4-7 parts of konjac flour, 2 parts of psyllium husk, 3-8 parts of xanthan gum, 2-5 parts of sucralose, 7-10 parts of silicon dioxide and 2-7 parts of food essence.
3. The high protein probiotic solid beverage according to claim 1, characterized in that: the edible lactobacillus comprises maltodextrin, Lactobacillus plantarum LP45, Lactobacillus acidophilus La28, Lactobacillus paracasei YMC1069, and Bifidobacterium bifidum TMC 3115.
4. The high protein probiotic solid beverage according to claim 1, characterized in that: the conjugated linoleic acid glyceride microcapsule powder comprises conjugated linoleic acid glyceride, oligomeric maltose, sodium caseinate, silicon dioxide and dipotassium hydrogen phosphate.
5. The high protein probiotic solid beverage according to claim 1, characterized in that: the medium chain triglyceride microcapsule powder comprises medium chain triglyceride, resistant dextrin, sodium caseinate, silicon dioxide and sodium tripolyphosphate.
6. The high protein probiotic solid beverage according to claim 1, characterized in that: the compound vitamin comprises dl-alpha-tocopherol acetate, retinyl acetate, D-pantothenic acid, pyridoxine hydrochloride, thiamine sulfate, nuclear sulfonic acid, cholecalciferol, nicotinic acid, folic acid, cyanocobalamine, and maltodextrin.
7. The high protein probiotic solid beverage according to claim 1, characterized in that: the compound mineral comprises calcium carbonate, magnesium carbonate, zinc oxide and maltodextrin.
8. The high protein probiotic solid beverage according to claim 1, characterized in that: the whey protein is concentrated whey protein, and the soybean phospholipid can be replaced by phospholipid.
9. A method of using the high protein probiotic solid beverage according to any one of claims 1 to 8, characterized in that: the method comprises the following steps:
the method comprises the following steps: weighing a proper amount of soybean protein isolate, whole milk powder, resistant dextrin, polymaltose powder, oat crisp particles, skimmed milk powder, whey protein, fish collagen peptide powder, white kidney bean extract, conjugated linoleic acid glyceride microcapsule powder, medium-chain triglyceride microcapsule powder, compound mineral substances, compound vitamins and soybean phospholipids, preparing a mixture, and performing bacteria reduction treatment to obtain a main material for later use;
step two: weighing appropriate amount of isomaltooligosaccharide, stachyose, rhizoma Amorphophalli powder, Plantago ovata forsk, xanthan gum, sucralose, silicon dioxide and food essence, mixing in a mixing device, and performing antibacterial treatment to obtain adjuvants;
step three: taking a proper amount of refrigerated lactobacillus plantarum LP45, lactobacillus acidophilus La28, lactobacillus paracasei YMC1069 and bifidobacterium bifidum TMC3115, airing to room temperature in a sterile environment, then injecting into a mixing device, injecting a proper amount of maltodextrin, and mixing uniformly to prepare the edible lactobacillus for later use;
step four: mixing the prepared main material and auxiliary material in a mixing device, adding appropriate amount of sterile water, stirring at 30-35 deg.C for 25-30min to obtain mixed powder, and mixing the prepared edible lactobacillus with the mixed powder uniformly;
step five: and then concentrating the prepared liquid, quickly freezing the concentrated liquid into pills, carrying out freeze-drying and crushing treatment on the structure, then carrying out aseptic filling, and packaging and coding to obtain the probiotic solid beverage.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011625157.5A CN112806437A (en) | 2020-12-31 | 2020-12-31 | High-protein probiotic solid beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011625157.5A CN112806437A (en) | 2020-12-31 | 2020-12-31 | High-protein probiotic solid beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112806437A true CN112806437A (en) | 2021-05-18 |
Family
ID=75854727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011625157.5A Pending CN112806437A (en) | 2020-12-31 | 2020-12-31 | High-protein probiotic solid beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112806437A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114304649A (en) * | 2022-01-05 | 2022-04-12 | 珠海大爱科技有限公司 | Low-carbon water protein rod and preparation method thereof |
| CN114711417A (en) * | 2022-04-28 | 2022-07-08 | 浙江译美生物科技有限公司 | Composite nutrition powder and preparation method and processing equipment thereof |
| CN115251373A (en) * | 2022-08-12 | 2022-11-01 | 中科爱伽(天津)医用食品有限公司 | Special dietary food for controlling weight, preparation process and application thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108703375A (en) * | 2018-04-04 | 2018-10-26 | 大连医诺生物股份有限公司 | Weight losing function food containing conjugated linoleic acid |
| CN109673747A (en) * | 2018-11-28 | 2019-04-26 | 天津活力达生物科技有限公司 | A kind of high protein has the generation meal milk shake solid beverage of full abdomen fat reducing effect |
| CN110447906A (en) * | 2019-09-10 | 2019-11-15 | 江西人之初营养科技股份有限公司 | A kind of composition and preparation method thereof for helping to control weight |
| CN110477236A (en) * | 2019-09-05 | 2019-11-22 | 广州秋草堂健康科技有限公司 | A kind of rhizoma polygonati protein solid beverage |
| CN110754655A (en) * | 2019-11-01 | 2020-02-07 | 广州景腾医疗科技有限公司 | Low-fat type total nutrient formula and preparation method thereof |
| CN111264661A (en) * | 2020-03-23 | 2020-06-12 | 浙江有迹贸易有限公司 | Weight-losing coffee powder and preparation method thereof |
| CN111631264A (en) * | 2020-04-22 | 2020-09-08 | 奇佳宜(北京)健康科技有限责任公司 | High-protein high-dietary-fiber fruit and vegetable meal replacement milk shake solid beverage and application thereof |
| CN111657353A (en) * | 2020-05-26 | 2020-09-15 | 颜如玉医药科技有限公司 | Fermented vegetable protein composite peptide nutritional meal replacement milk shake and preparation method thereof |
| CN112057479A (en) * | 2020-11-16 | 2020-12-11 | 招远新兴化工有限公司 | Probiotic composition capable of relieving diarrhea caused by antibiotics |
-
2020
- 2020-12-31 CN CN202011625157.5A patent/CN112806437A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108703375A (en) * | 2018-04-04 | 2018-10-26 | 大连医诺生物股份有限公司 | Weight losing function food containing conjugated linoleic acid |
| CN109673747A (en) * | 2018-11-28 | 2019-04-26 | 天津活力达生物科技有限公司 | A kind of high protein has the generation meal milk shake solid beverage of full abdomen fat reducing effect |
| CN110477236A (en) * | 2019-09-05 | 2019-11-22 | 广州秋草堂健康科技有限公司 | A kind of rhizoma polygonati protein solid beverage |
| CN110447906A (en) * | 2019-09-10 | 2019-11-15 | 江西人之初营养科技股份有限公司 | A kind of composition and preparation method thereof for helping to control weight |
| CN110754655A (en) * | 2019-11-01 | 2020-02-07 | 广州景腾医疗科技有限公司 | Low-fat type total nutrient formula and preparation method thereof |
| CN111264661A (en) * | 2020-03-23 | 2020-06-12 | 浙江有迹贸易有限公司 | Weight-losing coffee powder and preparation method thereof |
| CN111631264A (en) * | 2020-04-22 | 2020-09-08 | 奇佳宜(北京)健康科技有限责任公司 | High-protein high-dietary-fiber fruit and vegetable meal replacement milk shake solid beverage and application thereof |
| CN111657353A (en) * | 2020-05-26 | 2020-09-15 | 颜如玉医药科技有限公司 | Fermented vegetable protein composite peptide nutritional meal replacement milk shake and preparation method thereof |
| CN112057479A (en) * | 2020-11-16 | 2020-12-11 | 招远新兴化工有限公司 | Probiotic composition capable of relieving diarrhea caused by antibiotics |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114304649A (en) * | 2022-01-05 | 2022-04-12 | 珠海大爱科技有限公司 | Low-carbon water protein rod and preparation method thereof |
| CN114711417A (en) * | 2022-04-28 | 2022-07-08 | 浙江译美生物科技有限公司 | Composite nutrition powder and preparation method and processing equipment thereof |
| CN114711417B (en) * | 2022-04-28 | 2024-05-10 | 浙江译美生物科技有限公司 | Composite nutrition powder and preparation method and processing equipment thereof |
| CN115251373A (en) * | 2022-08-12 | 2022-11-01 | 中科爱伽(天津)医用食品有限公司 | Special dietary food for controlling weight, preparation process and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108812909B (en) | Complementary food nutritional supplement for improving monophagia or anorexia and preparation method thereof | |
| CN105146614B (en) | A kind of functional calcium fruit ferment, enzyme beverage and its production method | |
| CN112806437A (en) | High-protein probiotic solid beverage and preparation method thereof | |
| CN105995976A (en) | Integrated enzyme powder having effects of reducing fat and losing weight and application thereof | |
| CN106173773A (en) | A kind of ferment probiotic bacteria solid beverage and preparation method thereof | |
| CN107897381A (en) | A kind of modulation milk powder of adjustment function of intestinal canal containing lactase and preparation method thereof | |
| CN101564133B (en) | Soybean yogurt and preparation method thereof | |
| CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
| CN108935709A (en) | A kind of probiotics goat milk piece and preparation method thereof | |
| CN112056398A (en) | Yak milk freeze-dried yogurt block capable of promoting intestinal peristalsis | |
| CN106720456A (en) | Solid beverage composition containing WPC and preparation method thereof | |
| CN108785331A (en) | It is a kind of that there is qi-blood tonifying composition and its preparation method and application | |
| CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
| CN108935704A (en) | A kind of probiotics goat milk powder and preparation method thereof | |
| CN107334156A (en) | Lactagogue full nutrition formula food | |
| CN104187643A (en) | All-nutrition formula food for yang-deficiency constitution | |
| CN105639393A (en) | Ginseng probiotics food capable of improving fatigue resistance of human bodies | |
| CN106858261A (en) | A kind of lactobacillus-fermented accelerator and its application for Juice fermentation | |
| CN110178903A (en) | A kind of adult formula's milk powder with stimulating milk secretion and chest enlarge effect | |
| CN102742654B (en) | Beautification probiotic ewe milk tablet and preparation method thereof | |
| EP4056053A1 (en) | Pre-conditioning of l. reuteri | |
| CN114009508A (en) | Nutritional combined milk powder for coordinating gastrointestinal health and improving obesity and preparation method thereof | |
| CN114586844A (en) | Durian yogurt capable of reducing blood fat and relaxing bowel and preparation method thereof | |
| JP2004154086A (en) | Malted rice/soymilk-containing yoghurt food and method for producing the same | |
| CN103918793B (en) | A kind of stomach strengthening and digestion promoting probio goat milk sheet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: 510000 room 1301, 455 HuiFu East Road, Yuexiu District, Guangzhou City, Guangdong Province (office use only) Applicant after: Guangzhou Jingteng Medical Technology Co.,Ltd. Address before: 510000 room 1301, 455 HuiFu East Road, Yuexiu District, Guangzhou City, Guangdong Province (office use only) Applicant before: GUANGZHOU JINGTENG MEDICAL TECHNOLOGY Co.,Ltd. |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210518 |